Skip to content
Search

Latest Stories

PDA joins International Pharmaceutical Federation

The Pharmacists’ Defence Association (PDA) has become a member of the International Pharmaceutical Federation (FIP).

On Thursday (22 September), the FIP council voted to welcome the PDA as a full member of the global federation of organisations that brings together and advances pharmacy.


Mark Koziol, PDA chairman, said: "Being admitted to FIP with such a decisive level of support from its Council means that the PDA can ensure that UK pharmacists can enjoy a clear and powerful voice representing their collective professional interests at global level, which of late they could not.

"Bringing one of the largest pharmacy membership organisations in the world to FIP also gives the PDA significant influence in being able to inform the policies of the World Health Organisation. This means that the PDA can do even more for members by helping to make pharmacy practice more professionally fulfilling for them.”

“The PDA constantly seeks ways to provide even better support for members; membership of FIP will give the PDA much more influence and will result in better outcomes for pharmacists,” the association said.

To support humanitarian crises in other parts of the world, the PDA approached FIP, as a global pharmacy leadership organisation.

It said: “Timing was important, as it transpired that FIP was in the process of reorganising itself into six regions of the world. This would undoubtedly enable FIP to become much more responsive regionally and be able to rely on local expertise – a key lesson learned in the ‘Medicines to Ukraine’ campaign. It was evident that if the PDA joined FIP, it could actively participate in a programme which would deliver what many of the PDA's members had requested.”

“To that end, Mark in his capacity as General Secretary of EPhEU, was invited to raise this new and important humanitarian dimension at one of the main conference sessions. This additionally meant that whilst at the world congress, the PDA was able to identify various like-minded FIP member organisations from around the world with which to pursue this important work.”

The association also said: “In addition to the above, like many in the profession, the PDA was disappointed to discover just recently that the Royal Pharmaceutical Society had withdrawn from FIP membership nearly two years ago. This meant that UK pharmacists would have been left with no UK pharmacist organisational representation at global level within this important organisation. Joining FIP was a way to address both of these concerns.”

FIP membership will cost the PDA around 70 pence per member. This is the cost of the widening participation in change and access to experiences, collaborating with some of the most innovative pharmacy organisations in the world, and learning from and contributing to research and development on a global scale as well as the availability of resources that membership brings.

The PDA remains an independent organisation focussed on pharmacists in the UK, but, as a member of FIP, will be part of the global federation. This includes having a significant say on FIP’s governance and decision making where the PDA, because of its relatively large size (35,000+ members), will carry more votes than other smaller membership organisations.

PDA is also a member of the Employed Pharmacists of the European Union (EPhEU), the International Pharmaceutical Federation (FIP), the General Federation of Trade Unions (GFTU), the Irish Congress of Trade Unions (ICTU), and the Scottish Trade Union Congress (STUC).

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less